Virtu Financial LLC Intercept Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $256,163 - $479,761	25,642 New	25,642 $475,000
Q1 2023 May 01, 2023	BUY	$12.53 - $21.71 $220,640 - $382,291	17,609 New	17,609 $236,000
Q3 2022 Nov 07, 2022	BUY	$12.21 - $19.7 $239,999 - $387,223	19,656 New	19,656 $274,000
Q2 2021 Sep 17, 2021	SELL	$15.46 - $24.5 $184,298 - $292,064	-11,921 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$19.33 - $37.75 $38,853 - $75,877	2,010 Added 20.28%	11,921 $275,000

Q4 2020 Feb 24, 2021	BUY	$24.48 - $42.47 $242,621 - $420,920	9,911 New	9,911 $245,000
Q3 2020 Dec 11, 2020	SELL	$39.09 - $53.44 $978,227 - $1.34 Million	-25,025 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$46.7 - $92.04 $1.17 Million - $2.3 Million	25,025 New	25,025 $1.2 Million
Q4 2019 Feb 04, 2020	SELL	$57.36 - $124.1 $211,084 - $456,688	-3,680 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$58.69 - $80.46 $215,979 - $296,092	3,680 New	3,680 $244,000
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $249,563 - $387,262	-3,209 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$91.83 - $120.68 $195,873 - $257,410	-2,133 Reduced 39.93%	3,209 $359,000
Q4 2018 Jan 16, 2019	BUY	$85.79 - $126.46 $458,290 - $675,549	5,342 New	5,342 $538,000
Q2 2018 Jul 30, 2018	SELL	$60.0 - $85.67 $159,060 - $227,111	-2,651 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$60.0 - $85.67 $159,060 - $227,111	2,651 New	2,651 $222,000
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $211,038 - $269,201	-4,003 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $232,974 - $291,258	4,003	4,003 $234,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.